HC Wainwright Weighs in on Edap Tms FY2029 Earnings

Edap Tms S.A. (NASDAQ:EDAP) – Analysts at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for Edap Tms in a report issued on Friday, March 28th. HC Wainwright analyst S. Ramakanth expects that the medical equipment provider will post earnings per share of $0.40 for the year. HC Wainwright has a “Buy” rating and a $19.00 price objective on the stock. The consensus estimate for Edap Tms’ current full-year earnings is ($0.60) per share.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings data on Thursday, March 27th. The medical equipment provider reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.06. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. The firm had revenue of $22.69 million during the quarter, compared to the consensus estimate of $20.83 million.

A number of other research firms have also recently weighed in on EDAP. Piper Sandler lowered their price objective on shares of Edap Tms from $5.00 to $4.50 and set an “overweight” rating for the company in a research report on Friday. StockNews.com initiated coverage on Edap Tms in a research report on Friday. They set a “hold” rating for the company.

Edap Tms Price Performance

Shares of EDAP opened at $1.96 on Monday. The firm has a 50-day simple moving average of $2.42 and a two-hundred day simple moving average of $2.49. The stock has a market cap of $72.72 million, a PE ratio of -3.02 and a beta of 0.37. Edap Tms has a 1-year low of $1.96 and a 1-year high of $8.50. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.18 and a quick ratio of 1.46.

Institutional Trading of Edap Tms

Several hedge funds have recently made changes to their positions in EDAP. Illumine Investment Management LLC acquired a new position in shares of Edap Tms in the fourth quarter valued at approximately $50,000. Orion Capital Management LLC boosted its position in Edap Tms by 10.4% in the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock valued at $178,000 after buying an additional 6,600 shares during the period. Parkman Healthcare Partners LLC acquired a new position in shares of Edap Tms in the third quarter worth $395,000. Millennium Management LLC increased its position in shares of Edap Tms by 218.5% during the fourth quarter. Millennium Management LLC now owns 48,915 shares of the medical equipment provider’s stock worth $108,000 after acquiring an additional 33,558 shares during the period. Finally, Jane Street Group LLC increased its position in shares of Edap Tms by 174.7% during the fourth quarter. Jane Street Group LLC now owns 31,361 shares of the medical equipment provider’s stock worth $69,000 after acquiring an additional 73,361 shares during the period. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.